Twenty-four-hour endothelin-1 secretory pattern in stroke patients

被引:17
作者
Franceschini, R
Gandolfo, C
Cataldi, A
Del Sette, M
Rolandi, A
Corsini, G
Rolandi, E
Barreca, T
机构
[1] Dept Internal Med, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Neurosci & Neurorehabil, Genoa, Italy
关键词
endothelin-1; ischemic stroke; secretory profile;
D O I
10.1016/S0753-3322(01)00059-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Endothelin-1 (ET-1) is a potent and long-acting vasoconstrictor peptide, which may play a role in the pathophysiology of a number of diseases. Controversial data exist on its role in human ischemic stroke. in order to ascertain whether changes in ET-1 plasma levels occur in ischemic stroke, plasma ET-1 levels and mean arterial pressure were determined in 15 patients at their first ischemic cerebral infarction and in 15 control subjects, over a 24-hour period. In stroke patients, mean 24-hour plasma ET-1 levels (4.9 +/- 0.5 ng/L) were higher (P < 0.05) than in control subjects (3.2 +/- 0.3 ng/L), and correlated with the mean size of the lesion, but not with the severity score of the neurological deficit, These results support the hypothesis that ET-1 levels reflect an indicator function for the amount of damaged cerebral tissue rather than a pathophysiological role. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:272 / 276
页数:5
相关论文
共 21 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Increasing plasma neopterin and persistent plasma endothelin during follow-up after acute cerebral ischemia [J].
Anwaar, I ;
Gottsäter, A ;
Lindgärde, F ;
Mattiasson, I .
ANGIOLOGY, 1999, 50 (01) :1-8
[3]  
ASPLUND K, 1985, STROKE, V16, P885
[4]   Endothelin antagonists [J].
Benigni, A ;
Remuzzi, G .
LANCET, 1999, 353 (9147) :133-138
[5]   HIGH PLASMA-LEVELS OF ENDOTHELIN-1 AND ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH ACUTE ISCHEMIC STROKE [J].
ESTRADA, V ;
TELLEZ, MJ ;
MOYA, J ;
FERNANDEZDURANGO, R ;
EGIDO, J ;
CRUZ, AF .
AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (12) :1085-1089
[6]   Clinical evidence for a neuromodulator action of endothelin in the hypothalamic-pituitary-adrenal axis in man [J].
Haak, T ;
Jungmann, E ;
Haak, E ;
Ehrlich, S ;
Usadel, KH .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1997, 105 (01) :46-52
[7]   Plasma endothelin-1 levels neither increase nor correlate with neurological scores, stroke risk factors, or outcome in patients with ischemic stroke [J].
Haapaniemi, E ;
Tatlisumak, T ;
Hamel, K ;
Soinne, L ;
Lanni, C ;
Opgenorth, TJ ;
Kaste, M .
STROKE, 2000, 31 (03) :720-725
[8]  
Hamann G F, 1993, J Stroke Cerebrovasc Dis, V3, P256, DOI 10.1016/S1052-3057(10)80070-9
[9]   EFFECTS OF ENDOTHELIN ON BLOOD-VESSELS OF THE BRAIN AND CHOROID-PLEXUS [J].
KADEL, KA ;
HEISTAD, DD ;
FARACI, FM .
BRAIN RESEARCH, 1990, 518 (1-2) :78-82
[10]  
Kanai H, 1996, CLIN NEPHROL, V46, P353